Haryana Resumes Ayushman Bharat Payments, Delays Withdrawal by 650 Private Hospitals

Chandigarh, August 6, 2025 — Hours before a mass withdrawal by 650 private hospitals was set to take effect under Ayushman Bharat – AB‑PMJAY, the Haryana State Health Agency (SHA) confirmed that payment processing has resumed. The release of new funding has halted the immediate threat to suspend services that would have affected 1.8 crore beneficiaries across the state.

 

The SHA began clearing claims on August 4, following receipt of the state’s budget allocation. Hospitals are being paid on a first‑in‑first‑out (FIFO) basis, and claims up to the first week of May 2025 have been settled. SHA officials noted that ₹2,900 crore has been disbursed to hospitals since the scheme launched, including ₹240.63 crore so far.

On July 28, the Haryana chapter of thehttp://Indian Medical Association Indian Medical Association (IMA) issued a warning. It threatened to pull hospitals out of the Ayushman scheme from August 7 if ₹500 crore in unpaid reimbursements were not cleared. Despite some payments, many hospitals had received just 10–15% of their claims since March.

 

SHA Actions and Reforms

 

The SHA has confirmed transparent processes via the National Health Authority (NHA) portal, using a 50-member doctor team to manage claim allocations impartially. Hospitals have an opportunity to upload missing documentation before deductions. If defaults occur, hospitals can appeal via a Medical Audit Committee, and 400 grievances have already been resolved via the CGRMS 2.0 platform.

To deepen transparency, IMA representatives are now included in district and state-level audit and grievance redress committees. NABH incentive applications continue under revised rules via the HEM 2.0 portal, replacing HEM 1.0.

Remaining Risks and Warnings

Despite the progress, IMA Haryana has maintained its stance. Former IMA President Dr Ajay Mahajan emphasised that unless all dues are satisfactorily cleared, hospitals may still withdraw services from August 7, disrupting planned surgeries and inpatient care. Emergency services would continue, but non-critical care may be

This crisis highlights a fragile ecosystem: hospitals provide free care upfront and rely heavily on government reimbursements. Prolonged delays strain operations and threaten the credibility of http://Ayushman BharatAyushman Bharat, India’s flagship universal health coverage programme. Maintaining timely public–private collaboration is essential for sustaining healthcare access across Haryana.

 

Related Posts

Yashoda Medicity’s Medical Tourism Footprint widens with Republic of Kazakhstan on Board

MOU signed for Patient Referrals, Tele-Consultations and Specialist Healthcare Collaboration Delhi NCR: Unveiled not long ago, Yashoda Medcity’s reputation as being best in class healthcare facility in Delhi NCR has…

Liver enters FATal Straits in India, AIIMS Experts red flag

In first for India, World Congress of Gastroenterology comes calling to asses GI disease burden New Delhi: As global and national burden of digestive diseases reach a critical crossroads, World…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre